Literature DB >> 16985823

The molecular basis of erectile dysfunction: from bench to bedside.

Jesse N Mills, Albaha Barqawi, Sweaty Koul, Hari Koul, Randall B Meacham.   

Abstract

Erectile dysfunction is a common problem affecting many men across all age groups. Its etiology is multifactorial. Hormonal, vascular, neurogenic, lifestyle, and psychological entities have all been implicated as causative agents. The molecular basis underlying its etiology and progression is complex and still challenges researchers in the field. Nonetheless, newly discovered common pathways and targets of its pathogenesis have opened a new era for both prevention and active treatment of the disease. This review describes some of the known molecular mechanisms contributing to erectile dysfunction and discusses the future of gene therapy for the disease.

Entities:  

Year:  2005        PMID: 16985823      PMCID: PMC1477577     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  29 in total

1.  Gene therapy. Repair kits for faulty genes.

Authors:  D Ferber
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

Review 2.  The epidemiology and pathophysiology of erectile dysfunction.

Authors:  A Melman; J C Gingell
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

3.  Penile venous surgery.

Authors:  T F Lue
Journal:  Urol Clin North Am       Date:  1989-08       Impact factor: 2.241

4.  Changes in Penile Morphometrics in Men with Erectile Dysfunction after Nerve-Sparing Radical Retropubic Prostatectomy.

Authors: 
Journal:  Mol Urol       Date:  1999

5.  Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats.

Authors:  R S Rogers; T M Graziottin; C-S Lin; Y W Kan; T F Lue
Journal:  Int J Impot Res       Date:  2003-02       Impact factor: 2.896

6.  Hormonal supplementation and erectile dysfunction.

Authors:  Antonio Aversa; Andrea M Isidori; Emanuela A Greco; Elisa Giannetta; Daniele Gianfrilli; Enrico Spera; Andrea Fabbri
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

Review 7.  Vasculogenic erectile dysfunction: newer therapeutic strategies.

Authors:  Mike B Siroky; Kazem M Azadzoi
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

8.  Coronary artery risk factors in patients with erectile dysfunction.

Authors:  Ahmed I El-Sakka; Ayman M Morsy; Bassam I Fagih; Ahmed H Nassar
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

9.  The role of Fas-mediated apoptosis after traumatic spinal cord injury.

Authors:  Osamu Yoshino; Hiroaki Matsuno; Hiroshi Nakamura; Kazuo Yudoh; Yumiko Abe; Takashi Sawai; Miwa Uzuki; Shin Yonehara; Tomoatsu Kimura
Journal:  Spine (Phila Pa 1976)       Date:  2004-07-01       Impact factor: 3.468

Review 10.  Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.

Authors:  S Yamagishi; M Takeuchi; Y Inagaki; K Nakamura; T Imaizumi
Journal:  Int J Clin Pharmacol Res       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.